EUVIMEDEUVIMED entdecken
Crossref

Risk factors related to the SARS‐CoV‐2 vaccine additional doses hesitancy among pregnant and non‐pregnant people of reproductive age and partners: A Brazilian cross‐sectional study

Charles M Charles iD, Marcelo Noles, Aline Munezero, Negli Gallardo, Luis Bahamondes, Silvana F Bento, Karla S de Pádua, Marta Nhauche, Sherly Metelus, José G Cecatti, Renato T Souza, Rodolfo C Pacagnella

International Journal of Gynecology & Obstetrics · 2024

DOI: 10.1002/ijgo.15512 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Gynecology & Obstetrics, 2024. Verfasst von Charles M Charles und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Universidade Estadual de Campinas - (UNICAMP), Campinas, SP, Brazil. Hauptthemen laut MEDLINE: COVID-19 Vaccines, COVID-19, Vaccination Hesitancy, SARS-CoV-2. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: SRH, part of the UNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), a cosponsored p…, World Health Organization.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The aim of this study was to assess the predictors of acceptance and hesitancy of additional doses of any SARS‐CoV‐2 (COVID‐19) vaccine among pregnant or recently pregnant and non‐pregnant people of reproductive age and partners in Brazil.

Methods

We conducted an online cross‐sectional study from June 2022 to April 2023 and invited women and partners between 18 and 49 years old to participate. We employed a snowball strategy to reach all potential eligible participants. Our primary outcome was the acceptance rate of the COVID‐19 booster vaccine. We estimated the frequency and percentage for the three groups and compared categorical variables using the Chi‐square test. Moreover, bivariate, backward stepwise regression, and subgroup analyses were performed to evaluate risk factors and predictors of COVID‐19 vaccine booster hesitancy. We reported the effect size as OR with a 95% CI.

Results

We included 1487 participants, and among them, 334 (22.5%) were pregnant or recently pregnant people, 905 (60.8%) were non‐pregnant people, and 247 (16.6%) were male partners. Pregnant and recently pregnant people showed greater hesitancy for the COVID‐19 vaccine booster than non‐pregnant people (28% vs 15%, P < 0.001) and male partners (28% vs 16%, P < 0.001). Non‐pregnant women accepted the COVID‐19 vaccine more often than pregnant or recently pregnant people (OR 1.75; 95% CI: 1.13–2.70). The associated factors to the reduced COVID‐19 vaccine booster acceptance were family income between US$ 566–945.00 (54%), evangelic religion (65%), concern about vaccine safety (80%) and perceived common vaccine importance (93%).

Conclusion

Pregnant people were more hesitant than non‐pregnant people to accept the COVID‐19 booster vaccine. Family income, religious beliefs, vaccine safety concerns, and perceived common vaccine importance were significant barriers to accepting COVID‐19 booster vaccines. The impact of these factors was more evident among pregnant or recently pregnant people, emphasizing the harmful effect of misinformation among this vulnerable population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19 VaccinesCOVID-19Vaccination HesitancySARS-CoV-2HumansFemaleCross-Sectional StudiesAdultBrazilPregnancyMaleMiddle AgedRisk FactorsYoung AdultAdolescentImmunization, SecondarySexual PartnersPregnancy Complications, Infectious

Stichwörter der Autor:innen

COVID‐19non‐pregnant peoplepredictorspregnant peoplevaccine acceptancevaccine hesitancy

Substanzen

COVID-19 Vaccines

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Universidade Estadual de Campinas - (UNICAMP), Campinas, SP, Brazil.
  • Provincial Health Administration, DPS Manica, Chimoio, Mozambique.
  • Campinas Reproductive Health Research Center (CEMICAMP), Campinas, Brazil.
  • Women's Hospital "Prof. Dr. José A Pinotti" - Center for Integral Attention to Women (CAISM), Universidade Estadual de Campinas (UNICAMP), Campinas, SP, Brazil.

ORCID-Profile: Charles M Charles

Förderung

  • SRH, part of the UNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), a cosponsored p…
  • World Health Organization

Zitieren

APA

Charles, C. M., Noles, M., Munezero, A., Gallardo, N., Bahamondes, L., Bento, S. F., de Pádua, K. S., Nhauche, M., Metelus, S., Cecatti, J. G., Souza, R. T., & Pacagnella, R. C. (2024). Risk factors related to the SARS‐CoV‐2 vaccine additional doses hesitancy among pregnant and non‐pregnant people of reproductive age and partners: A Brazilian cross‐sectional study. International Journal of Gynecology & Obstetrics. https://doi.org/10.1002/ijgo.15512

Vancouver

Charles CM, Noles M, Munezero A, Gallardo N, Bahamondes L, Bento SF, et al. Risk factors related to the SARS‐CoV‐2 vaccine additional doses hesitancy among pregnant and non‐pregnant people of reproductive age and partners: A Brazilian cross‐sectional study. International Journal of Gynecology & Obstetrics. 2024. doi:10.1002/ijgo.15512

BibTeX
@article{Charles2024,
  author = {Charles, Charles M and Noles, Marcelo and Munezero, Aline and Gallardo, Negli and Bahamondes, Luis and Bento, Silvana F and de Pádua, Karla S and Nhauche, Marta and Metelus, Sherly and Cecatti, José G and Souza, Renato T and Pacagnella, Rodolfo C},
  title = {Risk factors related to the SARS‐CoV‐2 vaccine additional doses hesitancy among pregnant and non‐pregnant people of reproductive age and partners: A Brazilian cross‐sectional study},
  journal = {International Journal of Gynecology & Obstetrics},
  year = {2024},
  doi = {10.1002/ijgo.15512}
}
Kostenlos starten →